US 7795305
CDDO-compounds and combination therapies thereof
granted A61KA61K31/203A61K31/275
Quick answer
US patent 7795305 (CDDO-compounds and combination therapies thereof) held by The Board of Regents of the University of Texas System expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/203, A61K31/275, A61K45/06